In order to keep our competitive edge, the Federal Drug Administration (FDA) is placing increased emphasis on strengthening both the field and application of regulatory science relative to pharmaceutical research, development, review, and post-market surveillance. ...
Four proposals that address drug advertising and marketing issues, which have not been widely discussed, may be incorporated into the final health care reform bill. 1) Of most concern to the pharmaceutical industry is a proposal to eliminate the tax deduction for...
